Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
[16] DPP-4 inhibitors (such as sitagliptin), which enhance incretin activity through a different mechanism Insulin therapy, particularly if oral agents and other injectables are unsuitable Traditional agents like metformin, sulphonylureas, or pioglitazone, depending on individual circumstances NICE guideline NG28 recommends individualised treatment approaches based on HbA1c targets, cardiovascular risk, renal function, and patient preferences
Blood sugar controlNot surprisingly, blood sugar control also features strongly in the evidence base
The active molecule is shared
Exenatide and the Treatment of Patients With Parkinsons Disease
US$ 22.38
US$ 22.59
US$ 21.32
